Figure 1. Best overall response regarding change in the target lesion measurement determined on the basis of the Response Evaluation Criteria in Solid Tumors (RECIST).
Follow-up of patients treated with retinoic acid for the control of radioiodine non-responsive advanced thyroid carcinoma. S.M. Coelho, F. Vaisman, A. Buescu, R.C.R. Mello, D.P. Carvalho and M. Vaisman.
Figure 1. Best overall response regarding change in the target lesion measurement determined on the basis of the Response Evaluation Criteria in Solid Tumors (RECIST).